SYNOPSYS INC SNPS
SYNOPSYS INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.1B | $6.1B | $5.3B | $5.1B | $4.2B | $3.7B | $3.4B | $3.1B | $2.7B | $2.4B |
| Gross profit | $5.4B | $4.9B | $4.3B | $3.7B | $3.3B | $2.9B | $2.6B | $2.4B | $2.1B | $1.9B |
| R&D expense | $2.5B | $2.1B | $1.8B | $1.6B | $1.5B | $1.3B | $1.1B | $1.1B | $908.8M | $856.7M |
| Operating income | $914.9M | $1.4B | $1.3B | $1.1B | $734.8M | $620.1M | $520.2M | $360.2M | $347.6M | $317.4M |
| Interest expense | — | — | $1.2M | $1.7M | $3.4M | $5.1M | $11.7M | $15.6M | $7.3M | $3.8M |
| Income tax | $56.0M | $99.7M | $90.2M | $139.4M | $49.2M | -$25.3M | $13.1M | -$69.0M | $246.5M | $62.7M |
| Net income | $1.3B | $2.3B | $1.2B | $984.6M | $757.5M | $664.3M | $532.4M | $432.5M | $136.6M | $266.8M |
| EPS (diluted) | $8.04 | $14.51 | $7.92 | $6.29 | $4.81 | $4.27 | $3.45 | $2.82 | $0.88 | $1.73 |
| Operating cash flow | $1.5B | $1.4B | $1.7B | $1.7B | $1.5B | $991.3M | $800.5M | $424.4M | $634.6M | $586.6M |
| Free cash flow | $1.3B | $1.3B | $1.5B | $1.6B | $1.4B | $836.6M | $602.4M | $325.4M | $564.2M | $519.7M |
| Cash & equivalents | $2.9B | $3.9B | $1.4B | $1.4B | $1.4B | $1.2B | $728.6M | $723.1M | $1.0B | $976.6M |
| Inventory | $365.2M | $361.8M | $325.6M | $211.9M | $229.0M | $192.3M | $141.5M | $122.4M | $61.9M | — |
| Total assets | $48.2B | $13.1B | $10.3B | $9.4B | $8.8B | $8.0B | $6.4B | $6.1B | $5.4B | $5.2B |
| Total liabilities | $19.9B | $4.1B | $4.1B | $3.9B | $3.5B | $3.1B | $2.3B | $2.7B | $2.1B | $2.0B |
| Shareholders' equity | $28.3B | $9.0B | $6.2B | $5.5B | $5.3B | $4.9B | $4.1B | $3.5B | $3.3B | $3.2B |
Growth · year-over-year · Revenue CAGR 12.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +15.1% | +15.2% | +4.7% | +20.9% | +14.1% | +9.7% | +7.7% | +14.5% | +12.5% | +8.0% |
| Net income growth | -41.1% | +84.0% | +24.9% | +30.0% | +14.0% | +24.8% | +23.1% | +216.7% | -48.8% | +18.1% |
| EPS growth | -44.6% | +83.2% | +25.9% | +30.8% | +12.6% | +23.8% | +22.3% | +220.5% | -49.1% | +21.0% |
| Free cash flow growth | +6.4% | -16.3% | -5.5% | +14.5% | +67.2% | +38.9% | +85.1% | -42.3% | +8.6% | +27.3% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-10-31. Facts plus Stocktoria's own computed scores — not investment advice.